back to key references main page
General CT: PET/CT
 
Go Ukihide Tateishi, MD UmioYamaguchi, MD KunihikoSeki, MD Takashi Terauchi, MD Yasuaki Arai, MD E.Edmund Kim, MD Dec 2007 Bone and Soft-Tissue Sarcoma: Preoperative Staging with Fluorine 18 Fluorodeoxyglucose PET/CT and Conventional Imaging
Go Sun Young Jeong, Kyung Soo Lee, Joungho Han, Byung-Tae Kim, Tae Sung Kim, Young Mog Shim, Jhingook Kim Dec 2007 Integrated PET/CT of Salivary Gland Type Carcinoma of the Lung in 12 Patients
Go John F. Bruzzi, FFRRCSI , Reginald F. Munden, MD , Mylene T. Truong, MD , Edith M. Marom, MD , Bradley S. Sabloff, MD , Gregory W. Gladish, MD , Revathy B. Iyer, MD , Tin-Su Pan, PhD , Homer A. Macapinlac, MD , Jeremy J. Erasmus, MD Dec 2007 PET/CT of Esophageal Cancer: Its Role in Clinical Management
Go Eric L. Rosen, MD PhD Nov 2007 FDG PET, PET/CT, and Breast Cancer Imaging
Go Ur Metser, Elka Miller, Hedva Lerman, Einat Even-Sapir Nov 2007 Benign Nonphysiologic Lesions with Increased l8F-FDG Uptake on PET/CT: Characterization and Incidence
Go Hyo Soon Lim, MD , Woong Yoon, MD , Tae Woong Chung, MD , Jae Kyu Kim, MD , Jin Gyoon Park, MD , Heoung Keun Kang, MD , Hee Seung Bom, MD , Jung Han Yoon, MD Nov 2007 FDG PET/CT for the Detection and Evaluation of Breast Diseases: Usefulness and Limitations
Go Klaus Strobel, MD Reinhard Dummer, MD Daniela B. Husarik, MD Marisol Perez Lago, MD Thomas F. Hany, MD Hans C. Steinert, MD Aug 2007 High-Risk Melanoma: Accuracy of FDG PET/CT with Added CT Morphologic Information for Detection of Metastases
Go Conrad Wittram, James A. Scott July 2007 F-FDG PET of Pulmonary Embolism
Go Niklaus G. Schaefer, MD Christian Taverna, MD Klaus Strobel, MD CathrinWastl Michael Kurrer, MD Thomas F. Hany, MD July 2007 Hodgkin Disease: Diagnostic Value of FDG PET/CT after First-Line Therapy-Is Biopsy of FDG-avid Lesions Still Needed?
Go A. Bassem Elaini, MD , Sanjay K. Shetty, MD , Vernon M. Chapman, MD ,Dushyant V. Sahani, MD Giles W. Boland, MD , Ann T. Sweeney, MD , Michael M. Maher, MD 'James T. Slattery, MRCPI, FFR(RCSI) Peter R. Mueller, MD , Michael A. Blake, MRCPI, FFR(RCSI), FRCR June 2007 Improved Detection and Characterization of Adrenal Disease with PET-CT
Go Schindera ST, Nelson RC, DeLong DM, Jaffe TA, Merkle EM, Paulson EK, Thomas J. May 2007 Integrated PET/CT of Pulmonary Neuroendocrine Tumors: Diagnostic and Prognostic Implications
Go Taira AV, Herfkens RJ, Gambhir SS, Quon A. March 2007 Detection of Bone Metastases: Assessment of Integrated FDG PET/CT Imaging
Go Wong TZ, Paulson EK, Nelson RC, Patz Jr. EF, Coleman RE. March 2007 Practical Approach to Diagnostic CT Combined with PET
Go Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Feb 2007 Bowel Hot Spots at PET-CT
Go Lee YK, Seo JB, Kim SS, Kim TH. Feb 2007 Thoracic Periaortic Fibrosis Mimicking Malignant Tumor: CT and 8F-FDG PET Findings
Go Blodgett TM, Meltzer CC, Townsend DW. Feb 2007 PET/CT: Form and Function
Tatsumi M, Cohade C, Nakamoto Y, Fishman EK, Wahl RL. Dec. 2005
Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience
Go Nakamoto Y, Cohade C, Tatsumi M, Hammoud D, Wahl RL. Nov. 2005 CT Appearance of Bone Metastases Detected with FDG PET as Part of the Same PET/CT Examination
Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S. Sept. 2005
Non-Small Cell Lung Cancer: Prospective Comparison of Integrated FDG PET/CT and CT Alone for Preoperative Staging
Go Subhas N, Patel PV, Pannu HK, Jacene HA, Fishman EK, Wahl RL. Aug. 2005 Imaging of Pelvic Malignancies with In-Line FDG PET-CT: Case Examples and Common Pitfalls of FDG PET
Gutman F, Alberini JL, Wartski M, Vilain D, Le Stanc E, Sarandi F, Corone C, Tainturier C, Pecking AP. Aug. 2005
Incidental Colonic Focal Lesions Detected by FDG PET/CT
Go Barker DW, Zagoria RJ, Morton KA, Kavanagh PV, Shen P. April 2005 Evaluation of Liver Metastases After Radiofrequency Ablation: Utility of I8F-FDG PET and PET/CT
Kazama T, Faria SC, Varavithya V, Phongkitkarun S, Ito H, Macapinlac HA. Feb. 2004
FDG PET in the Evalu-ation of Treatment for Lymphoma: Clinical Usefulness and Pitfalls
Go Gutzeit A, Antoch G, Kuhl H, Egelhof T, Fischer M, Hauth E, Goehde S, Bockisch A, Debatin J, Freudenberg L. Jan. 2005 Unknown Primary Tumors: Detection with Dual-Modality PET/CT—Initial Experience
Sironi S, Messa C, Mangili G, Zangheri B, Aletti G, Garavaglia E, Vigano R, Picchio M, Taccagni G, Del Maschio A, Fazio F. Nov. 2004
Integrated FDG PET/CT in Patients with Persistent Ovarian Cancer: Correlation with Histologic Findings
Go Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. Oct. 2004 PET-CT Fusion Imaging in Differenti-ating Physiologic from Pathologic FDG Uptake
Even-Sapir E, Parag Y, Lerman H, Gutman M, Levine C, Rabau M, Figer A, Metser U. Sept. 2004
Detection of Recurrence in Patients with Rectal Cancer: PET/CT after Abdominoperineal or Anterior Resection
Go Metser U, Goor O, Lerman H, Naparstek E, Even-Sapir E. June 2004 PET-CT of Extranodal Lymphoma
Rohren EM, Turkington TG, Coleman RE. May 2004
Clinical Applications of PET in Oncology
Go Kapoor V, McCook BM, Torok FS. April 2004 An Introduction to PET-CT Imaging
Asad S, Aquino SL, Piyavisetpat N, Fischman AJ. April 2004
False-Positive FDG Positron Emission Tomography Uptake in Nonmalignant Chest Abnormalities
Go Yoshida Y, Kurokawa T, Kawahara K, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, Kotsuji F. Jan. 2004 Incremental Benefits of FDG Positron Emission Tomography over CT Alone for the Preoperative Staging of Ovarian Cancer
Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Dec. 2003
Fluorodeoxyglucose Uptake in the Aortic Wall at PET/CT: Possible Finding for Active Atherosclerosis
Go Fayad LM, Cohade C, Wahl RL, Fishman EK. Nov. 2003 Sacral Fractures: A Potential Pitfall of FDG Positron Emission Tomography
Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. June 2003
Metastasis to Regional Lymph Nodes in Patients with Esophageal Squamous Cell Carcinoma: CT versus FDG PET for Presurgical Detection— Prospective Study
Go Kostakoglu L, Agress Jr. H, Goldsmith SJ. April 2003 Clinical Role of FDG PET in Evaluation of Cancer Patients